We are live on ! Find out more
CFM

Capricorn Fund Managers Portfolio holdings

AUM $1.27B
1-Year Est. Return 70.17%
This Fund
S&P 500
This Quarter Est. Return
+29.44%
1 Year Est. Return
+70.17%
3 Year Est. Return
+169.21%
5 Year Est. Return
10 Year Est. Return
AUM
$415M
AUM Growth
+$117M
Cap. Flow
+$84.1M
Cap. Flow %
20.26%
Top 10 Hldgs %
35.96%
Holding
106
New
47
Increased
17
Reduced
15
Closed
24

Top Buys

Rank Stock Value
1
ZYME icon
Zymeworks
ZYME
+$22.3M
2
GPCR icon
Structure Therapeutics
GPCR
+$10.3M
3
BLFS icon
BioLife Solutions
BLFS
+$9.91M
4
NUVB icon
Nuvation Bio
NUVB
+$9.84M
5
ALAB icon
Astera Labs
ALAB
+$8.36M

Sector Composition

Rank Sector Weight
1 Healthcare 44.36%
2 Technology 15.14%
3 Industrials 8.91%
4 Communication Services 8.61%
5 Consumer Discretionary 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDG icon
51
TransDigm Group
TDG
$71.3B
$2.66M 0.64%
+2,000
New +$2.62M
AXTA icon
52
Axalta
AXTA
$7.76B
$2.58M 0.62%
+80,000
New +$2.35M
HYG icon
53
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$2.52M 0.61%
31,308
-20
-0.1% -$1.61K
CVX icon
54
Chevron
CVX
$379B
$2.49M 0.6%
16,363
-2,622
-14% -$399K
CHWY icon
55
Chewy
CHWY
$9.87B
$2.18M 0.53%
+65,948
New +$2.29M
FYBR
56
DELISTED
Frontier Communications
FYBR
$1.97M 0.48%
+51,847
New +$1.96M
LOGC
57
DELISTED
ContextLogic
LOGC
$1.9M 0.46%
+250,000
New +$1.9M
TARS icon
58
Tarsus Pharmaceuticals
TARS
$2.68B
$1.8M 0.43%
21,982
-218,038
-91% -$16.3M
IBIT icon
59
iShares Bitcoin Trust
IBIT
$47.3B
$1.72M 0.41%
34,601
+7,111
+26% +$404K
JAZZ icon
60
Jazz Pharmaceuticals
JAZZ
$15.8B
$1.7M 0.41%
+10,000
New +$1.53M
TSHA icon
61
Taysha Gene Therapies
TSHA
$1.66B
$1.65M 0.4%
+300,000
New +$1.46M
SCHW
62
Charles Schwab
SCHW
$184B
$1.55M 0.37%
15,506
+1,889
+14% +$179K
BAC icon
63
Bank of America
BAC
$440B
$1.4M 0.34%
25,465
+3,545
+16% +$187K
UBER icon
64
Uber
UBER
$147B
$1.38M 0.33%
16,843
+3,322
+25% +$299K
KSPI icon
65
Kaspi.kz JSC
KSPI
$17.5B
$1.33M 0.32%
17,000
BN icon
66
Brookfield
BN
$107B
$1.29M 0.31%
28,112
+4,112
+17% +$187K
LQD icon
67
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
$1.26M 0.3%
11,442
+40
+0.4% +$4.45K
BUR icon
68
Burford Capital
BUR
$931M
$1.2M 0.29%
135,000
+35,000
+35% +$343K
PYPL icon
69
PayPal
PYPL
$50.1B
$1.18M 0.28%
20,162
-15,905
-44% -$1.03M
DIS icon
70
Walt Disney
DIS
$170B
$1.18M 0.28%
+10,332
New +$1.14M
CCEP icon
71
Coca-Cola Europacific Partners
CCEP
$47.8B
$1.14M 0.28%
+12,600
New +$1.14M
WH icon
72
Wyndham Hotels & Resorts
WH
$5.59B
$1.05M 0.25%
13,920
EVMN
73
Evommune Inc
EVMN
$417M
$1.03M 0.25%
+60,000
New +$1.13M
DNLI icon
74
Denali Therapeutics
DNLI
$3.84B
$1.03M 0.25%
+62,197
New +$1.05M
AS icon
75
Amer Sports
AS
$21.1B
$852K 0.21%
22,800
-67,200
-75% -$2.31M

Similar funds

Capricorn Fund Managers's Q4 2025 Portfolio in Review

As of Q4 2025, Capricorn Fund Managers held 106 positions worth $415M, up 39% from $298M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Capricorn Fund Managers deployed $84.1M of net new capital in Q4 2025, opening 47 new positions and adding to 17 existing holdings. Its largest new stake was Zymeworks: 1,022,840 shares worth $26.9M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Tarsus Pharmaceuticals, an estimated $16.3M trimmed.

  • Capricorn Fund Managers's largest Q4 2025 buy was Zymeworks: 1,022,840 shares worth $26.9M.
  • Capricorn Fund Managers added most to Waystar Holding Corp in Q4 2025, an estimated $8.31M increase.
  • Capricorn Fund Managers's biggest Q4 2025 reduction was Tarsus Pharmaceuticals, cutting an estimated $16.3M.
  • Capricorn Fund Managers fully exited Vera Therapeutics in Q4 2025, selling an estimated $13.1M.
  • Capricorn Fund Managers's ten largest holdings make up 36% of its $415M portfolio in Q4 2025.
  • Capricorn Fund Managers opened 47 new positions and closed 24 in Q4 2025.
  • Capricorn Fund Managers's portfolio value rose 39% quarter-over-quarter to $415M.

Based on Capricorn Fund Managers's 13F filing for Q4 2025, filed 21 Jan 2026.